NCT04180943 is a Phase 4 clinical trial of interscalene nerve block in Anesthesia, Local, sponsored by Bassett Healthcare.

Who is sponsoring NCT04180943?

NCT04180943 is sponsored by Bassett Healthcare.

What drugs are being tested in NCT04180943?

Interventions in NCT04180943: interscalene nerve block.

What condition does NCT04180943 study?

NCT04180943 studies Anesthesia, Local.

Is NCT04180943 still recruiting?

NCT04180943 is currently completed. Last updated 2 March 2022.

Last reviewed 2022-03-02 · How we verify

NCT04180943

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery

Completed Phase 4 Last updated 2 March 2022

What this trial tests

Phase 4 trial testing interscalene nerve block in Anesthesia, Local in 85 participants. Completed in 1 June 2021.

Timeline

13 December 2019

Primary endpoint
1 March 2021

1 June 2021

Quick facts

Lead sponsor	Bassett Healthcare
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	85
Start date	13 December 2019
Primary completion	1 March 2021
Estimated completion	1 June 2021
Sites	1 location across United States

Drugs / interventions tested

interscalene nerve block — full drug profile →

Conditions studied

Anesthesia, Local — all drugs for Anesthesia, Local →

Sponsor

Bassett Healthcare — full company profile →

Who can join

18 and older, any sex, with Anesthesia, Local. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized, single blinded clinical trial whose purpose is to assess the impact of liposomal bupivacaine (LB) in a single shot interscalene nerve block compared with standard bupivacaine (same dose) in a single shot interscalene nerve block in terms of postoperative pain control. Specifically, outpatient pain scores,use of postoperative pain medicine and patient-reported functional outcomes after shoulder arthroplasty surgery will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of interscalene nerve block

Trials testing the same drug.

NCT05739201 — ISB, SSNB, and PENG Block for Arthroscopic Shoulder Surgery · NA · unknown

Other recruiting trials for Anesthesia, Local

Currently open trials in the same condition.

NCT07337772 — Comparing Different Doses of Corticosteroids in Local Infiltration Analgesia (LIA) for Total Knee Arthroplasty · NA · recruiting
NCT06960317 — Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements · NA · recruiting
NCT06694714 — Split Face Study of the Duration of Local Anesthetics - Fourth Arm · Phase 4 · recruiting
NCT04706026 — A Pilot Study of Local Anesthesia for Inguinal Hernia Surgery in Older Adults · NA · recruiting
NCT06528288 — Effects of Erector Spinae Plane Block on Postoperative Pain Following Lumbar Fusion Surgery · NA · recruiting

Other Bassett Healthcare trials

Trials by the same sponsor.

NCT04474288 — The COVID-19 PUI Reality Check (CPRC) Study · completed
NCT04328012 — COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19 · Phase 2, PHASE3 · terminated
NCT04327791 — COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1) · Phase 2, PHASE3 · unknown
NCT04245683 — Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population · recruiting
NCT03592082 — Use of Bismuth Subsalicylate in Clostridium Difficile Colitis · Phase 4 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04180943 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bassett Healthcare
Last refreshed: 2 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04180943.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing